P3. 15-21 Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer.

Background: Published reports of first-line afatinib treatment efficacy, side-effects and resistance mechanism in the real-world setting are lacking. Method: A retrospective observational study of patients with EGFR mutant advanced non-small cell lung cancer (NSCLC) receiving first-line afatini...

Full description

Bibliographic Details

Main Authors:	Chai, Chee Shee, Liam, Chong Kin, Ho, G., A, Binti Alip, Pang, Y.
Format:	Article
Language:	en
Published:	Elsevier 2018
Subjects:	R Medicine (General) RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Online Access:	http://ir.unimas.my/id/eprint/22819/1/Real-World%20Experience%20of%20First-Line%20Afatinib.pdf http://ir.unimas.my/id/eprint/22819/ https://www.jto.org/article/S1556-0864(18)32855-7/fulltext
Tags:	Add Tag No Tags, Be the first to tag this record!